Phase II Study in Patients With Recurrent Non-Small-Cell Lung Cancer

NCT00063388 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small-Cell Lung Cancer

Interventions

BIOLOGICAL: Cetuximab

Sponsor

Eli Lilly and Company

Collaborators

[object Object]